Health Canada Moves to Reduce Opioid Abuse in Canada

This article was last updated on April 16, 2022

Canada: Free $30 Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
USA: Free $30 Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…

In an attempt to reduce Canada’s growing prescription-drug abuse problem, Ottawa has planned to force all makers of opioids, including the most popular painkiller oxycodone, to improve their products’ resistance to crushing, snorting or injecting for a quick high.

According to a recently published notice of intent, Health Canada has asked all makers to regulate that mentions only slow-release oxycodone by name. During an interview, Health Minister Rona Ambrose mentioned that she hopes to set tamper-resistance standards for all opioids, which is a precaution that would make Canada’s anti-abuse regime one of the strictest in the world. Ms. Ambrose stated that “oxy is not the only problem here from a public health point of view” and added that “we want to look at the broader class of opioids and, really, we’re leaving it to industry to come up with how they’re going to manage and innovate to address the regulation around tamper resistance…. That’s an aggressive step, I recognize.”

Studies have shown that opioid addiction is becoming a major public-health crisis since the last 15 years, as now Canada has become the second country to consume more of the morphine-like drugs per capita after the United States. According to a study published in the journal Addiction on Monday, opioid overdoses has taken more than 6,000 lives in Ontario alone between 1991 and 2010, half of which were under the age of 42. The study’s findings were in keeping with past research laying bare the toll of opioid addiction in Canada.

Share with friends
You can publish this article on your website as long as you provide a link back to this page.

Be the first to comment

Leave a Reply

Your email address will not be published.


*